SCHEMBL7146635

SCHEMBL7146635

CC1=CC(=C2C=C(C)C(=O)c3ccccc32)c2ccccc2C1=O

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDC25B P30305 6/20 0.68
MAPT P10636 6/20 0.68
ALDH1A1 P00352 6/20 0.68
CDC25A P30304 5/20 0.68
MEN1 O00255 4/20 0.68
KMT2A Q03164 4/20 0.68
BLM P54132 4/20 0.68
SMN1; SMN2 Q16637 4/20 0.68
LMNA P02545 4/20 0.68
CYP1A2 P05177 4/20 0.68
CYP3A4 P08684 4/20 0.68
TP53 P04637 4/20 0.68
IDO1 P14902 3/20 0.68
MAPK1 P28482 3/20 0.68
HPGD P15428 3/20 0.68
CYP2C9 P11712 3/20 0.68
CYP2C19 P33261 3/20 0.68
PLIN1 O60240 2/20 0.68
MAOA P21397 2/20 0.68
PLIN5 Q00G26 2/20 0.68

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7140356 1.00 CDC25B (0.68) CDC25BMAPTALDH1A1CDC25AMEN1
SCHEMBL15893567 0.85 ALDH1A1 (0.52) CDC25BMAPTALDH1A1CDC25AMEN1
SCHEMBL18877805 0.84 MAPT (0.50) CDC25BMAPTALDH1A1CDC25AMEN1
SCHEMBL24747396 0.82 IDO1 (0.49) CDC25BMAPTALDH1A1CDC25AMEN1
Menadione SCHEMBL29351164 0.81 MAPT (1.00) CDC25BMAPTALDH1A1CDC25AMEN1
Menadione SCHEMBL1364028 0.81 MAPT (1.00) CDC25BMAPTALDH1A1CDC25AMEN1
Menadione SCHEMBL19356853 0.81 MAPT (1.00) CDC25BMAPTALDH1A1CDC25AMEN1
Menadione SCHEMBL25970 0.81 MAPT (1.00) CDC25BMAPTALDH1A1CDC25AMEN1
Menadione SCHEMBL9807661 0.79 MAPT (0.95) CDC25BMAPTALDH1A1CDC25AMEN1
Menadione SCHEMBL9163371 0.79 MAPT (0.95) CDC25BMAPTALDH1A1CDC25AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030149285-A1 Method for producing 1,1' binaphthalenylidene-4,4'-diones HAUCK MICHAEL (CH) 2003-08-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030149285-A1 Method for producing 1,1' binaphthalenylidene-4,4'-diones SCO2, CBR1, NOX4 CDC25B 1261/4885MAPT 4468/4885ALDH1A1 282/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.